← All Stocks

Teleflex Incorporated

TFX · NYQ
$122.07+1.65%
52W Low: $100.1852W High: $145.00
Current: $122.07  ·  49% of 52-week range
HealthcareMedical Instruments & SuppliesNYQ
View live charts, options flow & technicals for Teleflex Incorporated → Open Dashboard

Teleflex Incorporated (TFX) is a healthcare company in the medical instruments & supplies industry with $2.25B in trailing revenue — analyst consensus: none.

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Key Statistics

Market Cap$5.17B
Revenue (TTM)$2.25B
EPS (TTM)$-0.52
EPS (Fwd est.)$10.95
Employees15,500
Forward P/E11.15
PEG Ratio0.16
Price / Sales2.29
Price / Book1.78
EV / EBITDA19.27
Beta (5Y)0.81

Analyst Consensus

Consensus
None
Analyst Price Target
+25.8% upside
Target: $153.55

Annual Revenue & Net Income

RevenueNet Income
'22
$2.79B
$360.00M
'23
$1.71B
$360.00M
'24
$1.70B
$70.00M
'25
$1.99B
$-910.00M

Earnings History


QuarterActual EPSEstimateResult
Aug 2026
$1.76
$1.28Beat (+37.4%)
May 2026
$1.39
$1.21Beat (+14.5%)
Feb 2026
$1.93
$3.75Miss (-48.5%)
Nov 2025
$3.67
$3.38Beat (+8.6%)

Next Earnings Report

Teleflex Incorporated is next expected to report earnings on 29 Oct 2026.

Profitability

55.1%
10.1%
-45.8%
Gross
Margin
Operating
Margin
Net
Margin
Revenue Growth (YoY)28.9%
Return on Equity-0.7%
Return on Assets1.7%

Balance Sheet

Cash & Equivalents$320.00M
Total Debt$2.94B
Net Position$2.61B (net debt)
Free Cash Flow (TTM)$180.00M
Debt / Equity101.10

Share Ownership

Institutions 114.6%
Insiders 0.6%
Institutional figure exceeds 100% due to short selling

Dividend

Annual Rate
$1.36
Yield
1.11%
Payout Ratio
2266.7%
Ex-Dividend Date
14 Aug 2026
5Y Avg Yield
0.70%

Related Stocks

LLYUNHJNJMRKABBVTMOPFEISRG

Frequently Asked Questions

What does Teleflex Incorporated (TFX) do?
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and…
What is TFX's market cap?
Teleflex Incorporated has a market capitalization of approximately $5.17B.
How much revenue does TFX generate?
Teleflex Incorporated generated $2.25B in trailing 12-month revenue.
What do analysts say about TFX?
The analyst consensus rating for Teleflex Incorporated is none, with a mean price target of $153.55. That implies +25.8% upside from the current price.
When does TFX report earnings?
Teleflex Incorporated is next scheduled to report earnings on 29 Oct 2026.
Does TFX pay a dividend?
Yes. Teleflex Incorporated pays a dividend with a current yield of 1.11%, at an annual rate of $1.36 per share.

View live charts, options flow, gamma exposure, earnings history, and technical analysis for Teleflex Incorporated on Apsis Markets.

Open Live Dashboard →